- Combined digital health platform will be one of North America's leading fully-integrated
health offerings, with a clinically-validated, broad continuum of
care to address mild, moderate, acute and chronic mental and
physical care
- Adds scale and strengthens CloudMD's financial profile –
CloudMD expects to have annualized revenues exceeding $185 million (a 19% increase from CloudMD's
current revenue run rate of $155
million), as well as improved gross margin of 35%,
post-close
- CloudMD to offer $1.22 in cash
and 2.285 common shares of CloudMD per MindBeacon share
- CloudMD is projected to have cash on hand exceeding
$60 million, post-close
TORONTO, Dec. 16, 2021 /CNW Telbec/ - MindBeacon
Holdings Inc. ("MindBeacon" or the "Company")
(TSX: MBCN) announces that the Management Information Circular (the
"Information Circular") and associated Form of Proxy
and Letter of Transmittal are being mailed to shareholders of
MindBeacon on Friday, December 17,
2021 in connection with a definitive arrangement agreement
(the "Arrangement Agreement") under which CloudMD Software
& Services Inc. ("CloudMD" or the "Purchaser")
(TSXV: DOC) will acquire all of MindBeacon's issued and outstanding
common shares for a combination of cash and shares valued at
approximately $116 million. Under the
terms of the Arrangement Agreement, each common share of MindBeacon
will be exchanged for $1.22 of cash
and 2.285 common shares of CloudMD. A copy of the letter to
MindBeacon shareholders is available below highlighting the key
benefits and reasons for the transaction.
With the ongoing pandemic, MindBeacon's Special Meeting of
Shareholders is to be held in a virtual only meeting format via
live webcast online at
https://web.lumiagm.com/458290597 on January 10, 2022 at 10:00
a.m. (Eastern time).
While these materials will be filed by MindBeacon under its
issuer profile and be available for viewing on the SEDAR website
(www.sedar.com), a copy of the letter to MindBeacon shareholders is
included below. Furthermore, the disclosure in this press release
supplements the disclosure in the Information Circular and is
deemed to be incorporated by reference into the Information
Circular.
How to Vote
Shareholders must vote their proxy before 10:00 a.m. (Eastern time) on January 6, 2022.
MindBeacon shareholders with questions or who need help voting
are encouraged to contact Kingsdale Advisors at 1-888-302-5677
toll-free within North America, or
1-416-867-2272 (for collect calls outside North America), or e-mail at
contactus@kingsdaleadvisors.com.
Letter to MindBeacon Shareholders
Dear Shareholders,
The board of directors (the "Board of Directors") of
MindBeacon cordially invites you to attend a special meeting (the
"Meeting") of the holders (the "Shareholders")
of common shares (the "Shares") of the Company to
be held in a virtual only meeting format via live webcast
online at https://web.lumiagm.com/458290597 on
January 10, 2022 at 10:00 a.m. (Eastern time).
Given the coronavirus (COVID-19) pandemic, its public health
impact, the associated current restrictions on and the risk in
attending large group gatherings and to mitigate risks to the
health and safety of the Company's community, Shareholders and
employees, the Company has made the decision to hold the Meeting in
a virtual only format. Shareholders, regardless of geographic
location and ownership, will have an opportunity to participate at
the Meeting and engage with the directors of the Company and
management by following the registration process outlined in the
Information Circular.
THE TRANSACTION
At the Meeting, Shareholders will be asked to consider and, if
deemed advisable, to approve a special resolution
(the "Arrangement Resolution") approving a statutory
plan of arrangement (the "Arrangement") under Section 192 of
the Canada Business Corporations Act involving the
Company and the Purchaser pursuant to which the Purchaser will
acquire all of the issued and outstanding Shares. Under the terms
of the Arrangement, the holders of Shares will receive, in exchange
for each Share, (i) $1.22 in cash
(the "Cash Consideration") and (ii) 2.285 validly
issued, fully paid and nonassessable common shares of the Purchaser
("Purchaser Shares") (collectively, the
"Consideration"). The Meeting is being called and the
Arrangement is being pursued pursuant to the Arrangement Agreement
entered into between the Purchaser and the Company on November 14, 2021.
BOARD RECOMMENDATION
The Board of Directors unanimously recommends that the
Shareholders vote FOR the Arrangement Resolution.
REASONS FOR THE ARRANGEMENT
The recommendation of the special committee of the Board of
Directors (the "Special Committee") and the Board of
Directors that Shareholders vote FOR the Arrangement
Resolution is based on various factors, including those presented
below. A full description of the information and factors considered
by the Special Committee and the Board of Directors is located in
the Information Circular.
- Ability to Participate in Future Potential Growth of the
Purchaser. The Share Consideration being offered to the
Shareholders under the Arrangement allows Shareholders to have an
opportunity to participate in any potential increase in the value
of the Purchaser after the Effective Date. The value of the
Purchaser after the Effective Date may benefit from, among other
things, the following:
- Strength of the Purchaser following Acquisition of the
Company. The Purchaser, after it has acquired the Company,
will have a digital health platform expected to be one of
North America's leading
fully-integrated health offerings, with a clinically-validated,
broad continuum of care to address mild, moderate, acute and
chronic mental and physical care.
- Increased Scale and Financial Strength. The Purchaser is
anticipated to benefit from a strong pro forma balance sheet, more
robust cash flow and improved ability to raise capital and issue
shares, each of which are expected to support the Purchaser's
organic and acquisitive growth initiatives following completion of
the Arrangement.
- Potential Revenue Opportunities and Customer
Diversification. The Purchaser will benefit from potential
cross-selling revenue opportunities from the Purchaser's current
five million covered lives, combined 5,500 corporate clients, and
the Company's strategic government and employer relationships. The
Purchaser will benefit from an increased customer base as a result
of acquiring the Company and will not have the concentration risk
that the Company has with the agreement with Ontario Telemedicine
Network, a division of Ontario Health, an agency established under
the Ministry of Health, for the provision of psychology services in
Ontario.
- Anticipated Operational Synergies. The Purchaser
has already identified cost savings of approximately
$2 million and cross-sell synergies and has started to plan
the integration of the Company's synergistic healthcare solutions
into its mental health services offerings. In addition, the
Purchaser believes there are an additional $2 million in
potential synergies available over time through the integration of
the Company and the Purchaser's other acquisitions.
- Accelerated U.S. Expansion. The Company's recent
acquisition of a U.S.-based mental health provider combined with
the Purchaser's U.S.-based digital services and a dedicated U.S.
sales team is expected to accelerate the expansion into the U.S.
through organic growth and new and/or expanding distribution
channels.
- Significant Premium to the Shareholders. The implied
offer price of $4.78 represents a
premium of approximately 49% to the seven (7)-day volume weighted
average price of the Shares as of November
12, 2021, the last trading day prior to the announcement of
the Arrangement.
- Certainty of Value and Liquidity. The Cash Consideration
being offered to the Shareholders under the Arrangement allows
Shareholders to immediately realize value for a portion of their
investment and provides certainty of value and immediate
liquidity.
- Canadian Tax Deferral. Shareholders who hold their
Shares as capital property, who are Eligible Holders, who receive
Purchaser Shares under the Arrangement and who properly complete
and file the required tax election, may benefit from a full or
partial Canadian tax deferral in respect of capital gains that
would otherwise be realized on the disposition of Shares. See
"Certain Canadian Federal Income Tax Considerations" in the
Information Circular.
- Fairness Opinion. The Board of Directors and the Special
Committee received an opinion from TD Securities, which provided
that, as of the date of such opinion, based upon and subject to the
assumptions, limitations and qualifications set out therein, the
Consideration to be received by the Shareholders pursuant to the
Arrangement is fair, from a financial point of view, to the
Shareholders. See "The Arrangement – Fairness
Opinion" in the Information Circular.
- Increased Trading Liquidity. The Purchaser after
completion of the Arrangement will have a broader shareholder base
and an expected increased trading liquidity and a larger public
float than the Company presently holds. The expected increased
market capitalization and trading liquidity upon completion of the
Arrangement is anticipated to broaden the Purchaser's investor
appeal with enhanced market interest and analyst coverage. By
contrast, the Company has historically experienced limited trading
liquidity, which makes it difficult for Shareholders to realize
meaningful liquidity through the public markets on which the Shares
trade.
- Consideration of Strategic Alternatives. The Board of
Directors and the Special Committee conducted a review of various
strategic alternatives, including the Company continuing to operate
as an independent stand-alone business, and the Company entering
into a strategic or sale arrangement with another interested party.
In furtherance of the foregoing, the Board of Directors and the
Special Committee took into consideration the potential rewards,
risks and uncertainties associated with these and other
alternatives, including stock market uncertainties which could
affect the value of the Shares. Following a consideration of the
alternatives available to the Company, the Board of Directors and
the Special Committee concluded that the Arrangement is the most
favourable alternative for the Company to pursue (and can be
achieved with less risk) than the value that might have been
realized through pursuing other alternatives reasonably available
to the Company. These included:
- Executing on Its Current Strategic Plan. The
Special Committee and the Board undertook a detailed assessment of
the current and anticipated future opportunities and risks
associated with the business operations, assets, financial
condition and prospects of the Company as an independent, publicly
traded company, including the challenges the Company has
experienced and the risks facing the Company described above under
"The Arrangement – Background to the Arrangement" in the
Information Circular; and
- Sale to a Potential Competing Bidder. It was the
Special Committee's and the Board of Directors' view that there was
significant uncertainty associated with realizing an alternative
transaction with another potential buyer on more attractive terms,
in light of the fact that that ten prospective strategic buyers
were contacted prior to entering into exclusivity with the
Purchaser and none of the other proposals provided for terms that
were more attractive than those offered by the Purchaser. The
Special Committee and the Board also identified the Purchaser as a
strong strategic partner for the Company with high synergistic
opportunities.
- Procedural Safeguards. For the Arrangement to proceed,
among other things, (i) the Arrangement Resolution must be approved
by not less than two-thirds of the votes cast at the Meeting by
Shareholders virtually present or represented by proxy and entitled
to vote at the Meeting, (ii) the Arrangement Resolution must be
approved by a simple majority of the votes cast at the Meeting by
Shareholders virtually present or represented by proxy and entitled
to vote at the Meeting, excluding for this purpose any person
required to be excluded pursuant to Section 8.1(2) of MI 61-101,
and (iii) the Arrangement must be approved by the Ontario Superior
Court of Justice (Commercial List), which will consider, among
other things, the fairness of the Arrangement. In addition,
Shareholders have been provided with Dissent Rights with respect to
the Arrangement.
- Arm's Length Negotiations and Oversight. The Arrangement
Agreement is the result of robust, arm's length negotiations
involving the Company, on the one hand, and the Purchaser, on the
other hand. Extensive financial, legal and other advice was
provided to the Special Committee and the Board of Directors. Such
advice included detailed financial advice from highly qualified
financial advisors, including with respect to remaining an
independent publicly traded company and continuing to pursue the
Company's business plan on a stand-alone basis.
- Director & Officer and Shareholder Support.
Directors, executive officers and the other Supporting
Shareholders, representing in the aggregate approximately 28% of
the issued and outstanding Shares, have entered into irrevocable
Support and Voting Agreements pursuant to which each has agreed to
vote in favour of the Arrangement Resolution, subject to customary
exceptions.
- Ability to Respond to Superior Proposal. Under the
Arrangement Agreement, the Board of Directors, in certain
circumstances prior to Shareholder approval being obtained in
respect of the Arrangement, is able to consider, accept and enter
into a definitive agreement with respect to a Superior Proposal, or
withdraw, modify or amend its recommendation that Shareholders vote
to approve the Arrangement Resolution. In the view of the Board of
Directors and the Special Committee, the amount of the Termination
Fee (being $4.1 million), which is
payable by the Company in certain circumstances described under
"Summary of Material Agreements – The Arrangement Agreement –
Termination – Termination Fees" in the Information Circular
would not preclude a third party from making a Superior
Proposal.
- Limited Conditions to Closing. The Purchaser's
obligation to complete the transaction is subject to a limited
number of customary conditions the Special Committee and the Board
of Directors believe are reasonable in the circumstances. The
completion of the Arrangement is not subject to any financing
condition or approval by shareholders of the Purchaser.
- Dissent Rights. Shareholders have the right to dissent
with respect to the Arrangement Resolution and demand payment of
the fair value of their Shares.
In the course of their deliberations, the Special Committee and
the Board of Directors also identified and considered a variety of
risks (as described in greater detail under "Risk
Factors" in the Information Circular) and potentially
negative factors relating to the Arrangement, including the
following:
- the risks to the Company if the Arrangement is not completed,
including the costs to the Company in pursuit of the Arrangement,
the diversion of management's attention away from conducting the
Company's business in the ordinary course and the potential impact
on the Company's current business relationships (including with
current and prospective employees, customers, suppliers and
partners);
- the limitations contained in the Arrangement Agreement on the
Company's ability to solicit alternative transactions from third
parties, as well as the fact that if the Arrangement Agreement is
terminated in certain circumstances the Company may be required to
pay the Termination Fee or the expense reimbursement, which may
adversely affect the Company's financial condition;
- the fact that if the Arrangement Agreement is terminated and
the Board of Directors decides to seek another transaction or
business combination, there is no assurance that the Company will
be able to find a party willing to pay greater or equivalent value
compared to the Consideration available to Shareholders under the
Arrangement or that the continued operation of the Company under
its current business model will yield equivalent or greater value
to Shareholders compared to that available under the Arrangement
Agreement;
- the restrictions imposed pursuant to the Arrangement Agreement
on the conduct of the Company's business and operations during the
period between the execution of the Arrangement Agreement and the
consummation of the Arrangement or the termination of the
Arrangement Agreement;
- the conditions to the Purchaser's obligation to complete the
Arrangement and the rights of the Purchaser to terminate the
Arrangement Agreement in certain circumstances;
- the fact that under the Arrangement Agreement, the Company's
directors and certain of its executive officers may receive
benefits that differ from, or be in addition to, the interests of
Shareholders generally as described under "The Arrangement –
Interests of Certain Persons in the Arrangement" in the
Information Circular; and
- other risks associated with the parties' ability to complete
the Arrangement.
In reaching their respective determinations, the Special
Committee and the Board of Directors also considered and evaluated,
among other things, current industry, economic and market
conditions and trends, including the impact of the COVID-19
pandemic; and other stakeholders, including creditors, employees,
customers and the communities in which the Company operates, and
noted in this regard the longer-term prospects of the Purchaser
whose financial and strategic resources are well-suited to the
underlying nature of the Company's business.
The Special Committee and the Board of Directors' reasons for
recommending the Arrangement include certain assumptions relating
to forward-looking information, and such information and
assumptions are subject to various risks. See "Management
Information Circular – Forward-Looking
Statements" and "Risk Factors" in the Information
Circular.
SUPPORT AGREEMENTS
The Company's directors and senior management team, together
with certain significant shareholders of the Company
(the "Supporting Shareholders"), have entered into
voting support agreements pursuant to which they have agreed to
vote their Shares, representing in aggregate approximately 28% of
the issued and outstanding Shares as of the Record Date (as defined
below), in favour of the Arrangement Resolution.
APPROVAL REQUIREMENTS
The Board of Directors has set the close of business on
November 29, 2021 (the "Record
Date") as the record date for determining the Shareholders who
are entitled to receive notice of, and to vote at, the Meeting.
Only persons shown on the register of Shareholders at the close of
business on that date, or their duly appointed proxyholders, will
be entitled to attend the Meeting and vote on the Arrangement
Resolution. Each Share entitled to be voted at the Meeting will
entitle the holder thereof as of the Record Date to one (1) vote at
the Meeting in respect of the Arrangement Resolution.
Pursuant to the interim order of the Ontario Superior Court of
Justice (Commercial List) dated December 10,
2021, as same may be amended, modified or varied, and
Multilateral Instrument 61-101 – Protection of Minority Security
Holders in Special Transactions ("MI 61-101"), the
Arrangement Resolution will require the affirmative vote of: (a) at
least two-thirds (2/3) of the votes cast by the Shareholders
present in person or represented by proxy and entitled to vote at
the Meeting; and (b) a simple majority of the votes cast by the
Shareholders present in person or represented by proxy and entitled
to vote at the Meeting, other than any person required to be
excluded for the purpose of such vote under Section 8.1(2) of MI
61-101.
The Arrangement is subject to customary closing conditions for a
transaction of this nature, including court and shareholder
approvals. If the necessary approvals are obtained and the other
conditions to closing are satisfied or waived, it is anticipated
that the Arrangement will be completed shortly after the Meeting
(on or about January 14, 2022), and
as a Shareholder, you will receive payment for your Shares shortly
after closing, provided, if you are a registered holder of Shares
(a "Registered Shareholder"), that the depositary receives
your duly completed letter of transmittal, together with any other
documents required by the depositary.
The notice of special meeting (the "Notice of Meeting")
and Information Circular contain a detailed description of the
Arrangement and set forth the actions to be taken by you at the
Meeting. You should carefully consider all of the relevant
information in the Notice of Meeting and the Information Circular
and consult with your financial, legal or other professional
advisors if you require assistance.
If you are a registered shareholder, we are asking you to
take two actions.
First, your vote is important regardless of how many Shares you
own. Shareholders are encouraged to vote in advance of the Meeting.
If you are a Registered Shareholder, whether or not you plan
to attend the Meeting, to vote your Shares at the Meeting, you can
either return a duly completed and executed form of proxy to the
Company's transfer agent, TSX Trust Company (the "Transfer
Agent"), Proxy Department, by mail at: P.O. Box 721 Agincourt,
ON M1S 0A1, or via the internet at
https://astvotemyproxy.com not later than 10:00 a.m. (Toronto time) on January 6, 2022 or, if
the Meeting is adjourned or postponed, prior to 10:00 a.m. (Toronto time) on the second (2nd)
business day before any adjournment or postponement of the Meeting.
If you hold Shares through a broker, investment dealer, bank, trust
company or other intermediary (a "Beneficial Shareholder"),
you should follow the instructions provided by your intermediary to
ensure your vote is counted at the Meeting.
Second, if the Arrangement is approved and completed, before the
Purchaser can issue the Consideration for your Shares, the
depositary will need to receive the applicable letter of
transmittal completed by you, together with the certificates
representing the Shares and any additional documents that may be
required. Registered Shareholders must complete, sign, date and
return the enclosed letter of transmittal. If you are a Beneficial
Shareholder, you will receive payment for your Shares through your
financial intermediary if the Arrangement is completed.
If you have any questions with regard to the procedures for
voting, please contact the Company's strategic shareholder advisor
and proxy solicitation agent, Kingsdale Advisors, by
telephone at 1-888-302-5677 toll-free in North America, 1-416-867-2272 (outside of
North America) or by e-mail at
contactus@kingsdaleadvisors.com.
On behalf of the Company, I would like to thank all of our
Shareholders for their continuing support.
Yours very truly,
(Signed) "Samuel L.
Duboc"
Chair, Board of Directors
About MindBeacon Holdings Inc.
MindBeacon provides a continuum of mental healthcare that
includes self-guided psychoeducational and wellness content,
Peer-to-Peer Support, Therapist Guided Programs and Live Therapy
Sessions all offered virtually through its secure and private
platform. As one of the first commercially available,
digitally-native platforms to offer therapist-assisted
internet-based Cognitive Behavioural Therapy in Canada, MindBeacon's professional service is
designed around end users – their health, their way. Working with
employers, insurance carriers and government ministries, MindBeacon
offers services that are accessible, available, affordable and,
most importantly, proven to be effective. MindBeacon is changing
the therapy landscape by making professional care available to
every person, no matter when, where and how they choose to access
it.
About CloudMD Software & Services Inc.
CloudMD (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) is digitizing the delivery of
healthcare by providing a patient-centric approach, with an
emphasis on continuity of care. By leveraging healthcare
technology, the Company is building one, connected platform that
addresses all points of a patient's healthcare journey and provides
better access to care and improved outcomes. Through CloudMD's
proprietary technology, the Company delivers quality healthcare
through a holistic offering including hybrid primary care clinics,
specialist care, telemedicine, mental health support, healthcare
navigation, educational resources, and artificial intelligence
(AI). CloudMD's Enterprise Health Solutions Division includes one
of the top 4 Employee Assistance Programs in Canada and offers one comprehensive, digitally
connected platform for corporations, insurers, and advisors to
better manage the health and wellness of their employees, and
customers.
CloudMD currently services a combined ecosystem of over 7,000
psychiatrists, approximately 4,500 therapists and counsellors,
approximately 4,000 psychologists, over 22,000 family physicians,
over 34,000 medical specialists, over 1,500 allied health
professionals, over 500 clinics, and over 5 million individuals
across North America. For more
information visit: https://investors.cloudmd.ca.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
FORWARD-LOOKING STATEMENTS
This press release contains "forward-looking statements" and
"forward-looking information" within the meaning of Canadian
securities laws. Forward-looking statements in this press release
include, but are not limited to, statements with respect to the
impact and benefits of the transaction, the mailing of the
Information Circular, anticipated timing for completion of the
transaction and receiving the required regulatory, court and
shareholder approvals. These statements are based upon information
currently available to MindBeacon. All information that is not
clearly historical in nature may constitute forward-looking
statements. In some cases, forward-looking statements may be
identified by the use of terms such as "forecast", "assumption" and
other similar expressions or future or conditional terms such as
"anticipate", "believe", "could", "estimate", "expect", "intend",
"may", "plan", "predict", "project", "will", "would", and "should"
or the negative of these terms or variations of them or similar
terminology. Forward-looking statements contained in this press
release are based on certain factors and assumptions made by
management of MindBeacon based on their current expectations,
estimates, projections, assumptions and beliefs regarding their
respective businesses and MindBeacon does not provide any assurance
that actual results will meet management's expectations. While they
consider these assumptions to be reasonable based on information
currently available to them, they may prove to be incorrect. Such
forward-looking statements are not guarantees of future events or
performance and by their nature involve known and unknown risks,
uncertainties and other factors, including but not limited to: (a)
the possibility that the Arrangement will not be completed on the
terms and conditions, or on the timing, currently contemplated, and
that it may not be completed at all, due to a failure to obtain or
satisfy, in a timely manner or otherwise, required shareholder and
court approvals and other conditions of closing necessary to
complete the Arrangement or for other reasons; (b) the possibility
of adverse reactions or changes in business relationships resulting
from the announcement or completion of the Arrangement; (c) risks
relating to the Company's ability to retain and attract key
personnel during the interim period; (d) the possibility of
litigation relating to the Arrangement; (e) business, operational
and financial risks and uncertainties relating to the COVID-19
pandemic; (f) other risks inherent to the Company's business and/or
factors beyond its control which could have a material adverse
effect on the Company or the ability to consummate the Arrangement;
and (g) those risks described in the respective Management's
Discussion and Analysis and Annual Information Form of MindBeacon
(which has been filed under its issuer profile on SEDAR and can be
accessed at www.sedar.com), that may cause the actual results,
performance or achievements to be materially different from any
future results, performance or achievements expressed or implied by
such forward-looking statements. Although MindBeacon has attempted
to identify important factors that could cause actual actions,
events or results to differ materially from those described in
forward-looking statements, other factors may cause actions, events
or results to be different than anticipated, estimated or intended.
There can be no assurance that such statements will prove to be
accurate as actual results and future events could vary or differ
materially from those anticipated in such forward-looking
statements. Accordingly, readers should not place undue reliance on
forward-looking information. MindBeacon does not undertake to
update any forward-looking information, whether as a result of new
information or future events or otherwise, except as may be
required by applicable securities laws.
SOURCE MindBeacon Holdings Inc.